Debates - Articles | WholeFoods Magazine

Dietary-Supplements-Nutrition-GettyImages-2273297795.jpeg

House Dietary Supplement Listing Act Sparks Debate Over FDA Product Registry

NPA and CRN take opposing positions on legislation requiring FDA registration of dietary supplement products.

May 8, 2026

A new House bill would require dietary supplement manufacturers to register products with FDA, reigniting debate between industry groups over transparency, regulatory burden, and the future of DSHEA oversight.

Farmer displaying freshly harvested ashwagandha (Withania somnifera) roots and leaves.

Debates

India’s Ashwagandha Leaf Ban Sparks Debate Over Safety, Science, and Supply Chain

The Government of India's directive banning ashwagandha leaves is igniting debate across the nutraceutical industry, pitting traditional use, modern science, and global supply chains against each other.

May 5, 2026

Maggie Jaqua, Content Director

The Government of India's restriction on ashwagandha leaves in nutritional supplements is sparking industry debate. Experts weigh safety, science, and supply chain impacts of the root-only directive.

Dietary supplements from medicinal herbs. Selective focus. Nature.

Industry Reacts to Dietary Supplement Listing Act of 2026

Needed transparency tool...or burdensome requirement that won’t protect consumers from bad actors? The debate over mandatory product listing for dietary supplements continues.

January 27, 2026

WholeFoods Magazine Staff

AHPA, CRN, and NPA react to the introduction of the Dietary Supplement Listing Act of 2026, renewing a debate within the natural products industry over the role of a mandatory product listing and dietary supplement oversight.

Positioning Plant Protein: What’s the Best Placement?

A flexitarian and an ethical vegan share their thoughts on shelf placement for plant-based foods.

March 13, 2020

WholeFoods Magazine Contributor

A flexitarian and an ethical vegan share their thoughts on shelf placement for plant-based foods.

Mandatory Product Listing: Beneficial, or Burdensome?

The FDA has suggested that a mandatory listing requirement for dietary supplements “could provide significant benefits by improving transparency." But is it necessary?

February 19, 2020

WholeFoods Magazine Contributor

The FDA has suggested that a mandatory listing requirement for dietary supplements could help ID “bad actors who put the public at risk and undermine consumer confidence in the entire industry." But is it really necessary?